drugset / Trial / NCT03845387
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
RandomizedParallel-groupOpen-labelTreatment
Summary
Objective of this study is to investigate the efficacy, safety and pharmacokinetics of KDT-3594 in patients with early Parkinson's disease without a concomitant medication of L-dopa.
Timeline
- Start
- 2019-02-26
- Primary completion
- 2020-02-21
- Completion
- 2020-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KDT-3594 | Unknown | — | Oral |
| Subject | Pramipexole | Unknown | — | Oral |